ABSTRACT
The milk's natural flora, or the starter, can preserve cheesemaking and allow for microbial competition. This investigation aimed to improve cheese safety and assess its characteristics using probiotic cell pellets (LCP) or cell-free extracts (CFS). Cheese samples were collected from different areas to investigate the current contamination situation. Six CFSs of probiotics were assessed as antifungal against toxigenic fungi using liquid and solid media and their aflatoxin reduction impact. The most effective CFS was chosen for cheese coating in nanoemulsion. Coated cheese with CFS, LCP, and LCP-CFS was assessed against control for changes in chemical composition, ripening indications, rheological properties, and microbiology. Results showed significant contamination levels in the collected samples, and toxic fungi were present. Lactobacillus rhamnosus CFS has aflatoxins reducibility in liquid media. During cheese ripening, uncoated cheese showed higher fat, protein, salt content, soluble nitrogen, total volatile fatty acids, tyrosine, and tryptophan contents than coated samples, except for LCP-coating treatment. Cheese rheology indicated that coating treatments had the lowest hardness, cohesiveness, gumminess, chewiness, and springiness compared to uncoated cheese. Uncoated cheese had the highest yeast and mold counts compared to the treated ones. The LCP-CFS-coated cheese showed no Aspergillus cells for up to 40 days. Uncoated Ras cheese recorded slightly lower flavor, body, texture, and appearance scores than coated cheeses. In conclusion, coating cheese with L. rhamnosus nanoemulsion has antifungal and antiaflatoxigenic properties, even for LCP, CFS, and CFS-LCP, which could extend cheese shelf life.
ABSTRACT
OBJECTIVE: Spergularia marina (L.) Griseb. (S. marina) is a sub-cosmopolitan species used as traditional phytotherapy based on diverse biological activities. It is native and widespread in the northern hemisphere, though introduced also into the southern hemisphere. The extract of another species 'Spergularia purpurea' has been traditionally used in Morocco against various diseases and S. marina, itself, is a local popular food in South Korea. In this context, we evaluated the potential antihypertensive and diuretic effects of S. marina water and n-butanol extracts in L-NAME-induced hypertensive rats vs. the well-known diuretic, furosemide. MATERIALS AND METHODS: After toxicity studies, selected doses were administered orally daily for one week. Mean arterial blood pressure (MABP), water/electrolyte clearance, renal functions, and serum electrolytes were assessed. Vascular reactivity of isolated aortic rings was evaluated under different incubating settings against various antagonists to unravel the mechanism of action. RESULTS: Both extracts significantly reduced the MABP. Only, the n-butanol fraction exerted a significant aquaresis, increasing electrolyte free-water clearance with a significantly decreased urinary Na+, K+, and C- excretion. The water extract significantly augmented the ACh-induced relaxation and attenuated the NE-induced aortic rings' contractile response. It also exhibited a direct relaxant effect on the NE-precontracted rings with intact or denuded endothelium. Blocking the vascular calcium channels by preincubation with nifedipine prevented the S. marina-induced relaxation, denoting a calcium channel blocking activity. CONCLUSIONS: The vasorelaxant and the differential diuretic effects of both extracts introduce S. marina as a potential novel antihypertensive agent with calcium channel blocking activity. To enrich cardiovascular therapeutics, human studies to confirm the efficacy and safety of S. marina in hypertension are warranted. GRAPHICAL ABSTRACT: https://www.europeanreview.org/wp/wp-content/uploads/Graphical-abstract.jpg.
Subject(s)
Antihypertensive Agents , Caryophyllaceae , Animals , Antihypertensive Agents/pharmacology , Antihypertensive Agents/therapeutic use , Aorta, Thoracic , Calcium , Calcium Channel Blockers/pharmacology , Calcium Channel Blockers/therapeutic use , Diuretics/pharmacology , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Rats , Vasodilator Agents/therapeutic useABSTRACT
OBJECTIVES: the aim of the current study was to assess the effect of a ß2-adrenoceptor agonist; namely salbutamol, on hyperalgesic as well as nerve dysfunction components of diabetic peripheral neuropathy. MATERIAL AND METHODS: the present study was conducted on 60 male Wistar albino rats divided into six groups. Groups I and II were normal control rats injected by a single i.p. injection of normal saline and received 2% gum acacia (Group I) or salbutamol (Group II) for six weeks, starting one week following saline injection. Groups III-VI: rats that were rendered diabetic by a single i.p. injection of STZ and received either 2% gum acacia, salbutamol, salbutamol and propranolol or salbutamol and atenolol, respectively daily orally for six weeks, starting one week following STZ injection. RESULTS: vehicle-treated diabetic rats exhibited: significant sciatic nerve dysfunction in the form of significantly prolonged distal latency and significantly decreased maximum peak and peak to peak amplitude of compound muscular action potential, significant thermal and mechanical hyperalgesia evidenced by significant decrease in hot plate latency, tail-flick latency and vocalization threshold, respectively. Salbutamol administration improved nerve dysfunction as well as thermal and mechanical hyperalgesia. These effects of salbutamol are most likely mediated by ß2-adrenoceptors evidenced by significant abolishment of salbutamol effects after administration of the non-selective rather than the selective beta blockers; propranolol and atenolol, respectively. CONCLUSIONS: chronic administration of salbutamol could ameliorate DPN, an effect which is most likely mediated by ß2-adrenoceptors.
Subject(s)
Adrenergic beta-2 Receptor Agonists/pharmacology , Diabetic Neuropathies/drug therapy , Receptors, Adrenergic, beta-2/metabolism , Adrenergic beta-2 Receptor Agonists/therapeutic use , Animals , Diabetic Neuropathies/chemically induced , Diabetic Neuropathies/physiopathology , Electrophysiological Phenomena/drug effects , Hyperalgesia/drug therapy , Male , Rats , Rats, Wistar , Streptozocin/adverse effectsABSTRACT
Cardiovascular disease (CVD) remains one of the most common causes of morbidity and mortality in patients with chronic renal disease. It has been recently postulated that the loss or reduced levels of renalase in patients with chronic renal disease are, at least in part, responsible for elevated plasma catecholamine levels, which leads to increased CVD. Therefore, the aim of the present study was to evaluate whether renalase administration might serve as a therapeutic drug, decreasing the severity of CVD in 5/6 nephrectomized (Nx) rats. The current study was conducted on 30 male Wistar albino rats divided into the following groups: group I: sham-operated rats that received phosphate-buffered saline (PBS) subcutaneously (s.c.) for 4 weeks following sham operation, group II: rats in which 5/6 Nx was done and then the rats received PBS daily s.c. for 4 weeks following 5/6 Nx, and group III: rats in which 5/6 Nx was done and then the rats received recombinant renalase daily s.c. for 4 weeks following 5/6 Nx. 5/6 nephrectomy resulted in a significant increase in mean arterial pressure, left ventricular (LV)/body weight ratio, LV hydroxyproline concentration, plasma creatinine, blood urea nitrogen (BUN), and noradrenaline (NA) levels as well as significant decrease in LV papillary muscle developed tension in group II compared with the sham-operated group I. Administration of renalase to group III resulted in significant amelioration of all studied parameters with the exception of plasma creatinine and BUN which were not significantly different from nontreated group II. The results of the current study identify renalase as a new therapeutic modality that might modulate cardiac function and systemic blood pressure in renalase-deficient states like chronic renal disease.
Subject(s)
Cardiotonic Agents/therapeutic use , Cardiovascular Diseases/prevention & control , Disease Models, Animal , Enzyme Replacement Therapy , Monoamine Oxidase/therapeutic use , Renal Insufficiency, Chronic/physiopathology , Animals , Cardiotonic Agents/administration & dosage , Cardiovascular Diseases/etiology , Cardiovascular Diseases/pathology , Cardiovascular Diseases/physiopathology , Heart Ventricles/drug effects , Heart Ventricles/pathology , Heart Ventricles/physiopathology , Hypertension/etiology , Hypertension/pathology , Hypertension/physiopathology , Hypertension/prevention & control , Hypertrophy, Left Ventricular/etiology , Hypertrophy, Left Ventricular/pathology , Hypertrophy, Left Ventricular/physiopathology , Hypertrophy, Left Ventricular/prevention & control , Injections, Subcutaneous , Male , Monoamine Oxidase/administration & dosage , Monoamine Oxidase/deficiency , Monoamine Oxidase/genetics , Nephrectomy/adverse effects , Papillary Muscles/drug effects , Papillary Muscles/pathology , Papillary Muscles/physiopathology , Random Allocation , Rats , Rats, Wistar , Recombinant Proteins/administration & dosage , Recombinant Proteins/therapeutic use , Severity of Illness Index , Sus scrofaABSTRACT
AIMS: The aim of the present study was to investigate the role of zinc (Zn) in pilocarpine-induced seizures and its interrelation with an antiepileptic drug, namely, valproic acid. METHODOLOGY: The study was carried out on 110 male Wistar albino rats that were divided into the following groups: Group I, control rats that received intraperitoneal (i.p.) saline vehicle; Groups II-V received Zn in a medium dose, Zn in a high dose, valproic acid in a therapeutic dose, as well as a combination of valproic acid with medium dose Zn, respectively, for 3 weeks before saline injection, Group VI received i.p. pilocarpine to induce seizures; Groups VII-XI received Zn in a medium dose, Zn in a high dose, valproic acid in a therapeutic dose, a combination of therapeutic dose of valproic acid with medium dose Zn, as well as a combination of subeffective dose of valproic acid with medium dose of Zn, respectively, for 3 weeks before pilocarpine injection. The seizure's latency and severity for each rat was recorded. Blood and brain hippocampal samples were collected for determination of serum neuron specific enolase (NSE), hippocampal Zn, interleukin-1 beta concentrations as well as hippocampal superoxide dismutase and caspase-3 activities. RESULTS: The results of the current study demonstrated that pretreatment with high dose of Zn exacerbated pilocarpine-induced seizures. Whereas, a medium dose of Zn and valproic acid either alone or in combination reduced the severity of pilocarpine-induced limbic seizures and increased the latency to attain the forelimb clonus. Also both drugs, either alone or in combination, ameliorated all studied biochemical parameters with the exception of hippocampal Zn concentration, which was only significantly increased by pretreatment with Zn, either alone or in combination with valproic acid. CONCLUSIONS: The present study highlights the antiepileptic role that could be played by Zn, when given in appropriate doses.
Subject(s)
Disease Models, Animal , Epilepsy/drug therapy , Valproic Acid/administration & dosage , Zinc/physiology , Animals , Drug Therapy, Combination , Epilepsy/chemically induced , Epilepsy/metabolism , Hippocampus/drug effects , Hippocampus/metabolism , Male , Pilocarpine/toxicity , Rats , Rats, Wistar , Zinc/administration & dosageABSTRACT
Imperforate hymen is relatively rare but it is the most frequently encountered obstructive anomaly of the female lower genital tract. The clinical presentation vary significantly from patient to patient depending on the age at diagnosis but in most cases the diagnosis is missed in early childhood and therefore the diagnosis is made after puberty when the patient present with haematocolpos, heamatometra.or both. When this happens, the presentation could even be tricky because the patient may presents with unlikely symptoms apart from cryptomenorhoea like, urinary retention or bowel obstruction or both. Here we present a 16 years old girl with imperforate hymen and presented with history of lower abdominal pain and distension associated with acute urinary retention. She was treated by hymenotomy and improved dramatically and was discharge 6th day post operatively. This case report is presented to address to clinicians the possibility of imperforate hymen with haematocolpos as a differential diagnosis in adolescent girls particularly those who have not started having their menses in their teens and present with acute urinary retention so that their external genitalia are carefully examined to exclude the possibility of imperforate hymen as a cause of acute urinary retention due to the haematocolpos.
Subject(s)
Hematocolpos/complications , Hymen/abnormalities , Urinary Retention/complications , Adolescent , Female , Hematocolpos/surgery , Humans , Hymen/surgery , Urinary Retention/surgerySubject(s)
Analgesics, Opioid/adverse effects , Anesthesia, General/adverse effects , Antiemetics/therapeutic use , Fentanyl/adverse effects , Metoclopramide/therapeutic use , Naloxone/therapeutic use , Narcotic Antagonists/therapeutic use , Postoperative Nausea and Vomiting/drug therapy , Adult , Aged , Female , Humans , Male , Middle Aged , Pilot Projects , Prospective StudiesABSTRACT
This study investigates the effect of suxamethonium vs rocuronium on the onset of haemoglobin desaturation during apnoea, following rapid sequence induction of anaesthesia. Sixty patients were randomly allocated to one of three groups. Anaesthesia was induced with lidocaine 1.5 mg.kg(-1), fentanyl 2 microg.kg(-1) and propofol 2 mg.kg(-1), followed by either rocuronium 1 mg.kg(-1) (Group R) or suxamethonium 1.5 mg.kg(-1) (Group S). The third group received propofol 2 mg.kg(-1) and suxamethonium 1.5 mg.kg(-1) only (Group SO). The median (IQR [range]) time to reach S(p)O(2) of 95% was significantly shorter in Group S (358 (311-373 [245-430]) s) [corrected] than in Group R (378 (370-393 [366-420]) s; p = 0.003), and shorter in Group SO (242 (225-258 [189-270]) s) [corrected] than in both Group R (p < 0.001) and Group S (p < 0.001). When suxamethonium is administered for rapid sequence induction of anaesthesia, a faster onset of oxygen desaturation is observed during the subsequent apnoea compared with rocuronium. However, time to desaturation is prolonged whenever lidocaine and fentanyl precede suxamethonium.
Subject(s)
Androstanols/pharmacology , Neuromuscular Depolarizing Agents/pharmacology , Neuromuscular Nondepolarizing Agents/pharmacology , Oxygen/blood , Succinylcholine/pharmacology , Adult , Androstanols/adverse effects , Anesthesia, General/methods , Anesthetics, Intravenous/pharmacology , Anesthetics, Local/pharmacology , Apnea/blood , Fasciculation/chemically induced , Female , Fentanyl/pharmacology , Humans , Intubation, Intratracheal , Lidocaine/pharmacology , Male , Middle Aged , Neuromuscular Blockade/methods , Neuromuscular Depolarizing Agents/adverse effects , Neuromuscular Nondepolarizing Agents/adverse effects , Rocuronium , Succinylcholine/adverse effects , Young AdultABSTRACT
The patient was a 39-year-old pregnant woman who was scheduled for cesarean section. Spinal anesthesia was induced using a 26-gauge needle with an atraumatic bevel. Postoperatively, the patient developed cranial subdural hematoma manifesting as severe non-postural headache, associated with right eye tearing, fifth cranial nerve palsy and left hemiparesis. The diagnosis was confirmed by computed tomography scan. The patient was managed by careful neurological follow-up associated with conservative treatment and recovered fully after 12 weeks. Our report reviews the literature on 46 patients who developed a postdural puncture headache complicated by subdural hematoma following spinal or epidural anesthesia. It is possible that postdural puncture headache left untreated may be complicated by the development of subdural hematoma. Patients developing a postdural puncture headache unrelieved by conservative measures, as well as the change from postural to non-postural, require careful follow-up for early diagnosis and management of possible subdural hematoma.
Subject(s)
Carcinoid Heart Disease/pathology , Carcinoid Heart Disease/surgery , Blood Pressure , Carcinoid Heart Disease/complications , Carcinoid Heart Disease/physiopathology , Humans , Jejunal Neoplasms/complications , Jejunal Neoplasms/diagnostic imaging , Male , Middle Aged , Monitoring, Intraoperative , Tomography, X-Ray ComputedABSTRACT
BACKGROUND: Epidural fentanyl 100 microg after lidocaine-epinephrine test dose has been shown to provide adequate analgesia in early labor. This investigation determines the effect of three different bolus doses of epidural fentanyl on duration and quality of analgesia during early first stage of labor. METHODS: In this prospective, double-blind study, 103 laboring nulliparous at cervical dilation <5 cm were enrolled. After an epidural test dose of lidocaine (60 mg) with epinephrine (15 microg), parturients received, randomly, bolus of epidural fentanyl 50, 75, or 100 microg, followed by a continuous infusion of epidural bupivacaine 0.0625% and fentanyl 3 microg/ml at a rate of 10 ml/h. Pain scores and maternal sedation, pruritus, nausea, and vomiting were recorded 10, 20, and 30 min after fentanyl, and every 30 min thereafter until first request for additional analgesia. RESULTS: Adequate analgesia was achieved in 87% (28/32), 94% (35/38), and 94% (31/33) in the fentanyl 50, 75, and 100 microg groups within 20 min. Mean duration of analgesia before re-dosing was significantly longer in fentanyl 100 and 75 microg groups (185.6+/-82.9 and 188.5+/-82.2 min, respectively) as compared with fentanyl 50 microg group (133.6+/-46.2 min, P<0.016). There was no difference in the incidence of maternal side effects or neonatal Apgar scores among the three groups. CONCLUSION: After a test dose of lidocaine-epinephrine, the three epidural fentanyl doses produced similar effective labor analgesia. However, epidural fentanyl 75 microg followed by epidural infusion of dilute bupivacaine and fentanyl produced longer duration of analgesia than fentanyl 50 microg followed by the same infusion, with no further prolongation when the dose of fentanyl was increased up to 100 microg.
Subject(s)
Analgesia, Epidural/methods , Analgesia, Obstetrical/methods , Bupivacaine/therapeutic use , Fentanyl/therapeutic use , Adult , Bupivacaine/adverse effects , Dose-Response Relationship, Drug , Female , Fentanyl/adverse effects , Humans , Mothers , Pain/drug therapy , Pregnancy , Time FactorsABSTRACT
The authors report a case of 66-year-old female patient, 55 kg, ASA I who, under general anesthesia in supine position, developed gradual hypoxemia (from a baseline PaO2 of 250 to 91 mmHg), carbon dioxide build up (from a baseline PaCO2 31 to 41 mmHg) associated with gradual hyperthermia up to 38.3 degrees C over seven hours, intraoperatively. These observations were noted while using a semi-closed carbon dioxide absorption circuit in conjunction with the Hygroster filter at a fresh gas flow of 4 1/min of 50% nitrous oxide in oxygen. While the ventilation pattern was unchanged throughout the procedure, there was a change in exhaled tidal and minute ventilation volume with a net decrease of 28 ml and 0.4 l/min respectively. Findings are probably the result of pulmonary atelecatasis under general anesthesia due to the use of a relatively high-inspired oxygen concentration (50%). In addition, the use of a high humidity and temperature heat moisture exchanger (HME) filter (Hygroster) in conjunction with the circle absorber system may have resulted in over humidification and aggravated the pulmonary atelecatasis over the long operative time.
Subject(s)
Anesthesia, General/adverse effects , Fever/etiology , Hypercapnia/etiology , Hypoxia/etiology , Aged , Anesthesiology/instrumentation , Blood Gas Analysis , Blood Pressure/physiology , Decompression, Surgical , Disease Progression , Equipment Failure , Female , Humans , Monitoring, Intraoperative , Preanesthetic Medication , Pulmonary Atelectasis/etiology , Pulmonary Atelectasis/physiopathology , Spinal Cord Compression/surgeryABSTRACT
During apnoea following induction of anaesthesia, morbidly obese patients may suffer a rapid decrease in oxygen saturation. This study compares pre-oxygenation alone with pre-oxygenation followed by nasopharyngeal oxygen insufflation on the onset of desaturation occurring during the subsequent apnoea. A randomised controlled trial was performed in 34 morbidly obese patients undergoing gastric bypass or gastric band surgery. Seventeen patients received nasopharyngeal oxygen supplementation following pre-oxygenation (Study group, body mass index = 41.8 (6.9) kg.m(-2)), and the other 17 patients received pre-oxygenation alone (Control group, body mass index = 42.7 (5.4) kg.m(-2)). Time from the onset of apnoea until S(p)o(2) fell to 95% was compared between the two groups with a cut-off of 4 min. In the control group, the S(p)o(2) fell from 100% to 95% during the subsequent apnoea in 145 (27) s, with a significantly negative correlation (r(2) = 0.66, p < 0.05) between the time to desaturation to 95% and the body mass index. In the study group, the S(p)o(2) was maintained in 16 of 17 patients at 100% for 4 min when apnoea was terminated. In conclusion, nasopharyngeal oxygen insufflation following pre-oxygenation in morbidly obese patients delays the onset of oxyhaemoglobin desaturation during the subsequent apnoea.
Subject(s)
Insufflation/methods , Obesity, Morbid/surgery , Oxygen Inhalation Therapy/methods , Preoperative Care/methods , Adult , Bariatric Surgery , Body Constitution , Body Mass Index , Female , Humans , Male , Middle Aged , Nasopharynx , Obesity, Morbid/blood , Obesity, Morbid/complications , Oxygen/blood , Oxyhemoglobins/metabolismABSTRACT
BACKGROUND AND OBJECTIVE: Ondansetron is widely used for the prophylaxis of postoperative nausea and vomiting, while haloperidol is an antiemetic that lacks recent data on efficacy and adverse effects. METHODS: In this prospective, randomized, double-blinded study involving 93 females undergoing gynaecological procedures under general anaesthesia, we compared the efficacy and adverse effects of prophylactic haloperidol 1 mg intravenous and ondansetron 4 mg intravenous vs. placebo. RESULTS: During the overall observation period (0-24 h), in the haloperidol, ondansetron and placebo groups respectively, the incidence of nausea and/or vomiting was 40.7% (11/27), 48.2% (13/27) and 55.5% (15/27), and the need of rescue antiemetics was 22.2% (6/27), 44.4% (12/27) and 40.7% (11/27), with P values >0.05 among the three groups. During the early observation period (0-2 h), in the haloperidol, ondansetron and placebo groups respectively, the incidence of nausea and/or vomiting was 13.7% (4/29), 26.6% (8/30) and 43% (13/30), and the need for rescue antiemetics was 6.8% (2/29), 26.6% (8/30) and 36.6% (11/30). Between haloperidol and placebo groups, the P value was 0.04 for nausea and/or vomiting, and was 0.01 for rescue antiemetics, in addition to lower nausea scores (P = 0.03). During the late observation period (2-24 h), no significant difference was shown among the three groups. CONCLUSION: The prophylactic administration of 1 mg intravenous haloperidol or 4 mg ondansetron, in female patients undergoing gynaecological surgery, did not improve the overall incidence of nausea and/or vomiting vs. placebo. However, haloperidol 1 mg proved to be an effective antiemetic in the early observation period without significant adverse effects.
Subject(s)
Antiemetics/therapeutic use , Gynecologic Surgical Procedures/methods , Haloperidol/therapeutic use , Ondansetron/therapeutic use , Postoperative Nausea and Vomiting/prevention & control , Adult , Analysis of Variance , Anesthesia, General/methods , Antiemetics/administration & dosage , Antiemetics/adverse effects , Double-Blind Method , Female , Haloperidol/administration & dosage , Haloperidol/adverse effects , Humans , Injections, Intravenous , Middle Aged , Ondansetron/administration & dosage , Ondansetron/adverse effects , Prospective Studies , Risk Factors , Time Factors , Treatment OutcomeABSTRACT
BACKGROUND AND OBJECTIVES: This study was undertaken to compare the effect of alpha-stat vs. pH-stat strategies for acid-base management on regional cerebral oxygen saturation (RsO2) in patients undergoing moderate hypothermic haemodilution cardiopulmonary bypass (CPB). METHODS: In 14 adult patients undergoing elective coronary artery bypass grafting, an awake RsO2 baseline value was monitored using a cerebral oximeter (INVOS 5100). Cerebral oximetry was then monitored continuously following anaesthesia and during the whole period of CPB. Mean +/- SD of RsO2, CO2, mean arterial pressure and haematocrit were determined before bypass and during the moderate hypothermic phase of the CPB using the alpha-stat followed by pH-stat strategies of acid-base management. Alpha-stat was then maintained throughout the whole period of CPB. RESULTS: The mean baseline RsO2 in the awake patient breathing room air was 59.6 +/- 5.3%. Following anaesthesia and ventilation with 100% oxygen, RsO2 increased up to 75.9 +/- 6.7%. Going on bypass, RsO2 significantly decreased from a pre-bypass value of 75.9 +/- 6.7% to 62.9 +/- 6.3% during the initial phase of alpha-stat strategy. Shifting to pH-stat strategy resulted in a significant increase of RsO2 from 62.9 +/- 6.3% to 72.1 +/- 6.6%. Resuming the alpha-stat strategy resulted in a significant decrease of RsO2 to 62.9 +/- 7.8% which was similar to the RsO2 value during the initial phase of alpha-stat. CONCLUSION: During moderate hypothermic haemodilutional CPB, the RsO2 was significantly higher during the pH-stat than during the alpha-stat strategy. However, the RsO2 during pH-stat management was significantly higher than the baseline RsO2 value in the awake patient breathing room air, denoting luxury cerebral perfusion. In contrast, the RsO2 during alpha-stat was only slightly higher than the baseline RsO2, suggesting that the alpha-stat strategy avoids luxury perfusion, but can maintain adequate cerebral oxygen supply-demand balance during moderate hypothermic haemodilutional CPB.
Subject(s)
Brain/metabolism , Cardiopulmonary Bypass , Hypothermia, Induced , Oximetry , Female , Humans , Hydrogen-Ion Concentration , Male , Middle AgedSubject(s)
Laryngoscopes , Oxygen Inhalation Therapy/methods , Equipment Design , Humans , Insufflation/methodsABSTRACT
BACKGROUND AND OBJECTIVE: Following strabismus surgery, immediate postoperative ophthalmic evaluation may be desired. Thus, an anaesthetic technique allowing rapid recovery of ocular motility is required. Saccadic eye movements is a biophysical monitor of ocular motility and may be used to assess recovery from anaesthesia. The aim of this study is to compare the time to the recovery of saccadic eye movements in patients, following one of two anaesthetic techniques: Propofol-remifentanil-based anaesthesia vs. sevoflurane-fentanyl-based anaesthesia. METHODS: Fifty adult patients undergoing strabismus surgery were randomly assigned to one of two groups: patients in Group R received induction and maintenance of anaesthesia with propofol and remifentanil, while patients in Group S received induction of anaesthesia with propofol and fentanyl and maintenance of anaesthesia with sevoflurane. Recovery from anaesthesia was measured from the time all anaesthetics were turned off and was assessed every 2 min. Recovery time was attained when patients were able to generate brisk saccadic eye movements. At recovery time, the ophthalmic evaluation was started. RESULTS: The mean recovery time of saccadic eye movements was significantly shorter in the Group R when compared to the Group S (12.1 +/- 4.3 min vs. 21.5 +/- 4.7 min, respectively, P < 0.0001). More patients in Group S experienced nausea and vomiting postoperatively as compared to Group R (9/25 vs. 2/25, respectively, P = 0.037). CONCLUSIONS: Propofol-remifentanil-based anaesthesia may be a useful technique in strabismus surgery when immediate postoperative ophthalmic evaluation is desired. When compared to sevoflurane maintenance of anaesthesia, it allows for a more rapid recovery from anaesthesia as judged by recovery of saccadic eye movements and a decreased incidence of postoperative nausea and vomiting.
Subject(s)
Anesthetics, Intravenous/pharmacology , Fentanyl/pharmacology , Methyl Ethers/pharmacology , Piperidines/pharmacology , Propofol/pharmacology , Saccades/drug effects , Adolescent , Adult , Aged , Biophysical Phenomena , Biophysics , Female , Humans , Male , Middle Aged , Postoperative Complications , Remifentanil , SevofluraneABSTRACT
This paper evaluates the effectiveness of nasopharyngeal oxygen insufflation following preoxygenation using the four deep breath technique within 30 s, on the onset of haemoglobin desaturation during the subsequent apnoea. Thirty ASA I or II patients were randomly allocated to one of two groups. In the study group (n = 15), pre-oxygenation was followed by insufflation of oxygen at a flow of 5 l.min(-1) via a nasopharyngeal catheter commenced at the onset of apnoea. In the control group, pre-oxygenation was not followed by nasopharyngeal oxygen insufflation (n = 15). In the control group, SpO2 fell to 95% within a mean (SD) apnoea time of 3.65 (1.15) min, whereas in the study group, SpO2 was maintained in all patients at 100% throughout the 6 min of apnoea, at which point apnoea was terminated and positive pressure ventilation commenced. We conclude that nasopharyngeal oxygen insufflation following pre-oxygenation using the four deep breath technique can delay the onset of haemoglobin desaturation for a significant period of time during the subsequent apnoea.